Assertio Holdings, Inc. (ASRT)
11.48
+0.35
(+3.14%)
USD |
NASDAQ |
Jan 16, 16:00
11.56
+0.08
(+0.70%)
After-Hours: 20:00
Assertio Holdings EPS Diluted (Quarterly): 1.612 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Altimmune, Inc. | -0.2126 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.44M |
| Revenue (Quarterly) | 49.46M |
| Total Expenses (Quarterly) | 38.01M |
| Enterprise Value | 25.20M |
| Gross Profit Margin (Quarterly) | 61.01% |
| Profit Margin (Quarterly) | 23.14% |
| Earnings Yield | -23.79% |
| Normalized Earnings Yield | -18.07 |